For others, it occurs specifically after meals, particularly large or fatty meals
This is especially important with GLP-1 medications because the effects can be subtle at first
Understanding the pharmacokinetics of Zepbound can enhance the efficacy of the treatment
Additionally, patients with type 2 diabetes who would benefit from weight loss represent ideal candidates, as tirzepatide produces weight reductions of approximately 10-15% of body weight in patients with diabetes (SURMOUNT-2) and 15-21% in patients without diabetes (SURMOUNT-1)
Like GLP-1 itself, and like an earlier drug, liraglutide, that was approved in 2010, it suppresses the release of glucagon a hormone secreted by the pancreas to raise blood sugar levels
Advances in the pharmacologic treatment of psoriasis: A comprehensive review